4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
DataMEDS AI, Inc. (MEDS) operates in the Medical Distribution industry and is headquartered in Tampa, United States. Its market capitalization is roughly $3 million. In the fiscal year ended 2025-12-31, MEDS reported $23M in revenue and ($101M) in net income.
DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers.
Interactive charts & full statements → Open the MEDS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $23M | $18M | $0M | $33M |
| Gross Profit | ($6M) | $2M | $0M | $6M |
| Operating Income (EBIT) | ($81M) | ($6M) | ($3M) | ($3M) |
| Net Income | ($101M) | ($7M) | ($3M) | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $2M | $3M | $8M | — |
| Gross Profit | $0M | $0M | ($8M) | $0M | $0M | — |
| Operating Income (EBIT) | ($7M) | ($6M) | ($13M) | ($32M) | ($6M) | — |
| Net Income | ($18M) | ($8M) | ($28M) | ($34M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $30M | $57M | $0M | $0M |
| Total Liabilities | $43M | $51M | $3M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MEDS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms